Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

A rare case of hyperproliferative gastropathy.

Sinagra E, Raimondo D, Pompei G, Sorrentino D.

Dig Liver Dis. 2014 Sep 9. pii: S1590-8658(14)00650-1. doi: 10.1016/j.dld.2014.08.033. [Epub ahead of print] No abstract available.

PMID:
25217225
[PubMed - as supplied by publisher]
2.

Long-term prevention of postoperative Crohn's disease recurrence with azathioprine: the wolf in the sheep clothing.

Robb PM, Sorrentino D.

Int J Colorectal Dis. 2014 Aug 21. [Epub ahead of print] No abstract available.

PMID:
25139367
[PubMed - as supplied by publisher]
3.

Tissue studies in screened first-degree relatives reveal a distinct Crohn's disease phenotype.

Sorrentino D, Avellini C, Geraci M, Dassopoulos T, Zarifi D, Vadala ľ di Prampero SF, Benevento G.

Inflamm Bowel Dis. 2014 Jun;20(6):1049-56. doi: 10.1097/MIB.0000000000000051.

PMID:
24788221
[PubMed - in process]
4.

Clinical progression of untreated bilateral Brown syndrome.

Sorrentino D, Warman R.

J AAPOS. 2014 Apr;18(2):156-8. doi: 10.1016/j.jaapos.2013.12.004.

PMID:
24698613
[PubMed - in process]
5.

Stopping anti-TNF agents in patients with Crohn's disease in remission: is it a feasible long-term strategy?

Sorrentino D, Nash P, Viladomiu M, Hontecillas R, Bassaganya-Riera J.

Inflamm Bowel Dis. 2014 Apr;20(4):757-66. doi: 10.1097/01.MIB.0000442680.47427.bf. No abstract available.

PMID:
24572206
[PubMed - in process]
6.

Pre-clinical Crohn's disease: diagnosis, treatment and six year follow-up.

Sorrentino D, Avellini C, Geraci M, Vadalà S.

J Crohns Colitis. 2014 Jul 1;8(7):702-7. doi: 10.1016/j.crohns.2013.12.008. Epub 2014 Jan 8.

PMID:
24411923
[PubMed - in process]
7.

Translational research and efficacy of biologics in Crohn's disease: a cautionary tale.

Auer K, Trachter R, Van den Bogaerde J, Bassaganya-Riera J, Sorrentino D.

Expert Rev Clin Immunol. 2014 Feb;10(2):219-29. doi: 10.1586/1744666X.2014.877839.

PMID:
24410538
[PubMed - in process]
8.

Infliximab vs adalimumab for Crohn's disease: perhaps too early to call it a tie.

Dassopoulos T, Sorrentino D.

Clin Gastroenterol Hepatol. 2014 May;12(5):818-20. doi: 10.1016/j.cgh.2013.12.006. Epub 2013 Dec 14. No abstract available.

PMID:
24342747
[PubMed - in process]
9.

Surgery for Crohn's disease and anti-TNF agents: the changing scenario.

Sorrentino D, Fogel S, Van den Bogaerde J.

Expert Rev Gastroenterol Hepatol. 2013 Nov;7(8):689-700. doi: 10.1586/17474124.2013.842895. Review.

PMID:
24161133
[PubMed - indexed for MEDLINE]
10.

Fibrocytes, inflammation, and fibrosis in Crohn's disease: another piece of the puzzle.

Sorrentino D.

Dig Dis Sci. 2014 Apr;59(4):699-701. doi: 10.1007/s10620-013-2888-2. No abstract available.

PMID:
24114044
[PubMed - indexed for MEDLINE]
11.

State-of-the-art medical prevention of postoperative recurrence of Crohn's disease.

Sorrentino D.

Nat Rev Gastroenterol Hepatol. 2013 Jul;10(7):413-22. doi: 10.1038/nrgastro.2013.69. Epub 2013 May 7. Review.

PMID:
23648935
[PubMed - indexed for MEDLINE]
12.

Child maltreatment: promising approaches and new directions.

Preer G, Sorrentino D, Ryznar E, Newton AW.

Curr Opin Pediatr. 2013 Apr;25(2):268-74. doi: 10.1097/MOP.0b013e32835eb347. Review.

PMID:
23429709
[PubMed - indexed for MEDLINE]
13.

Ustekinumab induction and maintenance therapy in refractory Crohn's disease.

Sandborn WJ, Gasink C, Gao LL, Blank MA, Johanns J, Guzzo C, Sands BE, Hanauer SB, Targan S, Rutgeerts P, Ghosh S, de Villiers WJ, Panaccione R, Greenberg G, Schreiber S, Lichtiger S, Feagan BG; CERTIFI Study Group.

N Engl J Med. 2012 Oct 18;367(16):1519-28. doi: 10.1056/NEJMoa1203572.

PMID:
23075178
[PubMed - indexed for MEDLINE]
Free Article
14.

Bringing top-end endoscopy to regional australia: hurdles and benefits.

Van Den Bogaerde J, Sorrentino D.

Diagn Ther Endosc. 2012;2012:347202. Epub 2012 Sep 9.

PMID:
22991487
[PubMed]
Free PMC Article
15.

The race for mainstream gastrointestinal endoscopy: frontrunners.

Seltenreich H, Van Den Bogaerde J, Sorrentino D.

Expert Rev Gastroenterol Hepatol. 2012 Aug;6(4):467-79. doi: 10.1586/egh.12.27. Review.

PMID:
22928899
[PubMed - indexed for MEDLINE]
16.

The role of magnetic resonance imaging in detecting intestinal fibrosis in Crohn's disease.

Fiorino G, Cesarini M, Malesci A, Danese S, Sorrentino D.

Curr Drug Targets. 2012 Sep 1;13(10):1273-9.

PMID:
22664085
[PubMed - indexed for MEDLINE]
17.

Mucosal healing and clinical remission in inflammatory bowel diseases: are we missing something here?

Sorrentino D.

Inflamm Bowel Dis. 2013 Mar-Apr;19(4):E55-6. doi: 10.1002/ibd.22999. No abstract available.

PMID:
22517503
[PubMed - indexed for MEDLINE]
18.

Clinical remission after stopping infliximab in Crohn's disease: is all that glitters true gold?

Sorrentino D, Radford-Smith G.

Gastroenterology. 2012 May;142(5):e17; author reply e18. doi: 10.1053/j.gastro.2012.02.054. Epub 2012 Mar 24. No abstract available.

PMID:
22453047
[PubMed - indexed for MEDLINE]
19.

Child abuse pediatrics: prevention, evaluation, and treatment.

Preer G, Sorrentino D, Newton AW.

Curr Opin Pediatr. 2012 Apr;24(2):266-73. doi: 10.1097/MOP.0b013e328350674d. Review.

PMID:
22426158
[PubMed - indexed for MEDLINE]
20.

Anti-TNFs for prevention of postoperative recurrence of Crohn's disease: a broken record?

Sorrentino D.

Inflamm Bowel Dis. 2012 Sep;18(9):1624-5; author reply 1626-7. doi: 10.1002/ibd.22919. Epub 2012 Feb 22. No abstract available.

PMID:
22359378
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk